Author:
Díaz-Conradi Alvaro,García-García Juan José,González Peris Sebastià,Fernández de Sevilla Mariona,Moraga Llop Fernando,Ventura Paula Sol,Domínguez Angela,Domínguez Angela,Moraga Llop Fernando,de Sevilla Mariona Fernández,González Peris Sebastià,Ciruela Pilar,Campins Magda,Muñoz-Almagro Carmen,Esteva Cristina,Izquierdo Conchita,Uriona Sonia,Martínez Osorio Johanna,Solé Ribalta Anna,Codina Gemma,Soldevila Nuria,Salleras Sanmartí Lluís
Subject
Pediatrics, Perinatology, and Child Health
Reference19 articles.
1. Epidemiología de la enfermedad invasiva neumocócica en Cataluña;Ciruela;Reporte 2012-2016. Agencia de Salut Publica de Catalunya;,2018
2. Effectiveness of the 13-valent pneumococcal conjugate vaccine in preventing invasive pneumococcal disease in children aged 7-59 months. A matched case-control study;Domínguez;PLoS One.,2017
3. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates;O’Brien;Lancet.,2009
4. Ficha técnica o resumen de las características de la vacuna antineumocócica polisacárida conjugada (13-valente, adsorbida) Pfizer. 2010. www.ema.europa.eu/docs/es_ES/document_library/../WC500057247.pdf.(Consultado el 6 de febrero de 2019.).
5. Association between respiratory syncytial virus activity and pneumococcal disease in infants: a time series analysis of US hospitalization data;Weinberger;PLoS Med.,2015